Literature DB >> 10495790

Cells isolated from the human cortical interstitium resemble myofibroblasts and bind neutrophils in an ICAM-1--dependent manner.

A Clayton1, R Steadman, J D Williams.   

Abstract

Progressive renal disease is frequently accompanied by renal interstitial inflammation and fibrosis in which the activity of resident fibroblasts may be of central importance. Because there are relatively few fibroblasts in the normal cortical interstitium and there is no specific marker to permit their identification, these cells have proved difficult to characterize in vitro. In this study, these cells were isolated and established in culture, using CD90 as a positive selection marker. Antibodies to CD90 bound to tubular epithelial cells and fibroblasts, but not to glomerular cells in kidney sections. In culture, only fibroblasts were CD90-positive. These normal renal cortical fibroblasts (RCF) were alpha-smooth muscle actin- and vimentin-positive, but desmin-, cytokeratin-, and factor VIII-negative, identifying them as myofibroblasts. They expressed platelet-derived growth factor alpha and beta receptors; CD44; and alpha 2, beta 1, and beta 3 integrin chains: this combination of markers was also characteristic of fibroblasts in sections of normal cortex. These cells were positive for ICAM-1 but negative for VCAM-1. Similarly, proliferating or growth-arrested renal cortical fibroblasts (RCF) in culture expressed ICAM-1 but not VCAM-1. The expression of VCAM-1 was detected, however, and that of ICAM-1 was increased on fibroblasts associated with inflammatory infiltrates in sections from fibrotic kidneys, and ICAM-1 and VCAM-1 were up-regulated on RCF in culture after incubation with increasing doses of interleukin-1 beta or tumor necrosis factor alpha (maximum between 24 and 48 h). These adhesion molecules were functional, and neutrophils adhered to resting and cytokine-activated RCF. Binding was maximal between 24 and 48 h after cytokine treatment and was inhibited by anti-CD18 antibodies. ICAM-1 is the principal adhesion molecule controlling inflammatory cell infiltration of the interstitium. The study presented here suggests that cortical fibroblasts may be central to the control of this infiltration.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 10495790     DOI: 10.1681/ASN.V84604

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  6 in total

Review 1.  Fibroblasts and myofibroblasts in renal fibrosis.

Authors:  Soma Meran; Robert Steadman
Journal:  Int J Exp Pathol       Date:  2011-02-28       Impact factor: 1.925

2.  Structural and functional changes in heparan sulfate proteoglycan expression associated with the myofibroblastic phenotype.

Authors:  Gareth Thomas; Aled Clayton; Janet Thomas; Malcolm Davies; Robert Steadman
Journal:  Am J Pathol       Date:  2003-03       Impact factor: 4.307

3.  Renal proximal tubular epithelial cell transforming growth factor-beta1 generation and monocyte binding.

Authors:  Xiao Liang Zhang; Wisam Selbi; Carol de la Motte; Vincent Hascall; Aled Phillips
Journal:  Am J Pathol       Date:  2004-09       Impact factor: 4.307

4.  Toll-like receptor signaling and SIGIRR in renal fibrosis upon unilateral ureteral obstruction.

Authors:  Veronika Skuginna; Maciej Lech; Ramanjaneyulu Allam; Mi Ryu; Sebastian Clauss; Heni Eka Susanti; Christoph Römmele; Cecilia Garlanda; Alberto Mantovani; Hans-Joachim Anders
Journal:  PLoS One       Date:  2011-04-22       Impact factor: 3.240

5.  Characterisation of feline renal cortical fibroblast cultures and their transcriptional response to transforming growth factor β1.

Authors:  J S Lawson; H M Syme; C P D Wheeler-Jones; J Elliott
Journal:  BMC Vet Res       Date:  2018-03-09       Impact factor: 2.741

6.  Progression of Alport Kidney Disease in Col4a3 Knock Out Mice Is Independent of Sex or Macrophage Depletion by Clodronate Treatment.

Authors:  Munkyung Kim; Alessandro Piaia; Neeta Shenoy; David Kagan; Berangere Gapp; Benjamin Kueng; Delphine Weber; William Dietrich; Iwona Ksiazek
Journal:  PLoS One       Date:  2015-11-10       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.